NMRD
Income statement / Annual
Last year (2023), Nemaura Medical Inc.'s total revenue was $77,044.00,
a decrease of 84.71% from the previous year.
In 2023, Nemaura Medical Inc.'s net income was -$14.14 M.
See Nemaura Medical Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
03/31/2023 |
03/31/2022 |
03/31/2021 |
03/31/2020 |
03/31/2019 |
03/31/2018 |
03/31/2017 |
03/31/2016 |
03/31/2015 |
03/31/2014 |
| Operating Revenue |
$77,044.00
|
$503,906.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Cost of Revenue |
$1.55 M |
$344,300.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Gross Profit |
-$1.48 M |
$159,606.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Gross Profit Ratio |
-19.16 |
0.32 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| Research and Development
Expenses |
$1.54 M
|
$1.56 M
|
$1.55 M
|
$2.01 M
|
$2.30 M
|
$993,833.00
|
$1.03 M
|
$1.03 M
|
$824,503.00
|
$383,857.00
|
| General & Administrative
Expenses |
$5.60 M
|
$6.17 M
|
$3.03 M
|
$2.77 M
|
$2.18 M
|
$915,132.00
|
$516,661.00
|
$511,413.00
|
$495,337.00
|
$202,376.00
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$5.60 M
|
$6.17 M
|
$3.03 M
|
$2.77 M
|
$2.18 M
|
$915,132.00
|
$516,661.00
|
$511,413.00
|
$495,337.00
|
$202,376.00
|
| Other Expenses |
$980,039.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Operating Expenses |
$7.14 M |
$7.73 M |
$4.59 M |
$4.78 M |
$4.48 M |
$1.91 M |
$1.55 M |
$1.54 M |
$1.32 M |
$586,233.00 |
| Cost And Expenses |
$9.67 M |
$8.07 M |
$4.59 M |
$4.78 M |
$4.48 M |
$1.91 M |
$1.55 M |
$1.54 M |
$1.32 M |
$586,233.00 |
| Interest Income |
$0.00 |
$6.67 M |
$2.01 M |
$3,926.00 |
$23,927.00 |
$88,516.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Interest Expense |
$6.41 M |
$6.67 M |
$2.01 M |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Depreciation &
Amortization |
$444,177.00
|
$229,810.00
|
$98,075.00
|
$54,840.00
|
$33,407.00
|
$29,256.00
|
$20,433.00
|
$17,404.00
|
$7,556.00
|
$5,099.00
|
| EBITDA |
-$8.17 M
|
-$7.34 M
|
-$4.49 M
|
-$4.72 M
|
-$4.44 M
|
-$1.88 M
|
-$1.53 M
|
-$1.52 M
|
-$1.31 M
|
-$581,134.00
|
| EBITDA Ratio |
-106.06 |
-14.57 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| Operating Income Ratio
|
-124.54
|
-15.02
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Total Other
Income/Expenses Net |
-$4.55 M
|
-$6.67 M
|
-$2.01 M
|
$3,926.00
|
$23,927.00
|
$88,516.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Income Before Tax |
-$14.14 M |
-$14.24 M |
-$6.59 M |
-$4.77 M |
-$4.45 M |
-$1.82 M |
-$1.55 M |
-$1.54 M |
-$1.32 M |
-$586,233.00 |
| Income Before Tax Ratio
|
-183.58
|
-28.25
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00 |
-$350,256.00 |
-$335,832.00 |
-$614,362.00 |
$23,927.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Net Income |
-$14.14 M |
-$13.89 M |
-$6.26 M |
-$4.16 M |
-$4.45 M |
-$1.82 M |
-$1.55 M |
-$1.54 M |
-$1.32 M |
-$586,233.00 |
| Net Income Ratio |
-183.58 |
-27.56 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| EPS |
-0.57 |
-0.59 |
-0.28 |
-0.2 |
-0.25 |
-0.0121 |
-0.0076 |
-0.0076 |
-0.0066 |
-0.0029 |
| EPS Diluted |
-0.57 |
-0.59 |
-0.28 |
-0.2 |
-0.25 |
-0.0121 |
-0.0076 |
-0.0076 |
-0.0066 |
-0.0029 |
| Weighted Average Shares
Out |
$24.88 M
|
$23.38 M
|
$22.28 M
|
$20.81 M
|
$18.09 M
|
$150.07 M
|
$205.00 M
|
$201.73 M
|
$200.00 M
|
$200.00 M
|
| Weighted Average Shares
Out Diluted |
$24.88 M
|
$23.38 M
|
$22.28 M
|
$20.81 M
|
$18.09 M
|
$150.07 M
|
$205.00 M
|
$201.73 M
|
$200.00 M
|
$200.00 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
